Abode Drugs Private Limited
About Abode Drugs Private Limited
Data last updated:
Abode Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 April 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2008PTC058838. Its GSTIN is 36AAHCA0614J1ZX (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prakash Rao Nayaneni and Prakash Sharat Kumar Naineni.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at H.No.5 – 4 – 22/1 Sri Rama Nilayam Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2019, the company reported a revenue of ₹78.84 Lakh, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹48,093 (net margin 0.6%) and EBITDA of ₹7.79 Lakh (EBITDA margin 9.9%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years.
As per MCA filings, the company has open charges of ₹29.79 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Abode Drugs has one previous CIN (Corporate Identification Number): U24232AP2008PTC058838. The current CIN is U24232TG2008PTC058838, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2008PTC058838 | Current |
| U24232AP2008PTC058838 | Previous |
Contact details
Abode Drugs Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressH.No.5 – 4 – 22/1 Sri Rama Nilayam Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Abode Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Abode Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Abode Drugs Private Limited, buy the company report.
Financials of Abode Drugs Private Limited
FY 2019 filings availableAbode Drugs Private Limited reported revenue of ₹78.84 Lakh (down 33% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 21% over three years, including a 33% fall in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹78.84 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48,093 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.9% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abode Drugs Private Limited, buy the company report.
Board of directors of Abode Drugs Private Limited
Abode Drugs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakash Rao Nayaneni | Director | 25 Apr 2008 | 18 Years 6 Months | Current |
| Prakash Sharat Kumar Naineni Also directs: Abode Biotec India Private Limited | Director | 25 Apr 2008 | 18 Years 6 Months | Current |
Peer comparison
Abode Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| S M X Farma Limited | ₹79 Lakh (FY 2025) | -88.0% | Delhi, India | |||
| A S Pharmaceutical (India) Private Limited | ₹78.99 Lakh (FY 2024) | -18.0% | Chennai, Tamil Nadu, India | |||
| Abode Drugs Private Limitedthis company | ₹78.84 Lakh (FY 2019) | ₹48,093 | 0.6% | -33.0% | Hyderabad, Telangana, India | |
| Agshov Pharmaceuticals Private Limited | ₹78.43 Lakh (FY 2024) | 9.0% | North Twenty Four Pargana, West Bengal, India | |||
| Ranaux Healthcare Private Limited | ₹78.32 Lakh (FY 2025) | -1.0% | Delhi, India |
To see the full peer comparison of Abode Drugs Private Limited, buy the company report.
Auditor
Abode Drugs Private Limited is audited by P V REDDY & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P V REDDY & ASSOCIATES | FY 2017 | 010236S |
Shareholding
The shareholding of Abode Drugs Private Limited is on record for FY 2016, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Abode Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Feb 2021 | 100443716 | Hdfc Bank Limited | ₹15.38 Lakh | Open | |
| 25 Jan 2021 | 100443091 | Hdfc Bank Limited | ₹14.41 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Abode Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abode Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Abode Drugs Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
Abode Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCA0614J1ZX | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Abode Drugs Private Limited, buy the company report.
Recent activity
Abode Drugs Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Prakash Rao Nayaneni was appointed as Director on 25 Apr 2008.
Frequently asked questions
Abode Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 April 2008 (18+ years old) and is registered under CIN U24232TG2008PTC058838.
Abode Drugs has 2 current directors:
- Prakash Rao Nayaneni - Director
- Prakash Sharat Kumar Naineni - Director
The latest financial statements of Abode Drugs on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Abode Drugs is 36AAHCA0614J1ZX, registered in Telangana.
The CIN (Corporate Identification Number) of Abode Drugs is U24232TG2008PTC058838. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abode Drugs was incorporated on 25 April 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Abode Drugs by revenue are S M X Farma Limited, A S Pharmaceutical (India) Private Limited, Agshov Pharmaceuticals Private Limited, Ranaux Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Prakash Rao Nayaneni was appointed as Director on 25 Apr 2008. Prakash Sharat Kumar Naineni was appointed as Director on 25 Apr 2008.
The registered office of Abode Drugs is at H.No.5 – 4 – 221 Sri Rama Nilayam Kukatpally, Hyderabad, Telangana, India – 500072.
Abode Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Abode Drugs has open charges of ₹29.79 Lakh and no satisfied charges on record as per latest MCA filings.